Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cohort Study of the Benefits of Bydureon in Customary Clinical Care in the United States

NCT02974244 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02974244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02974244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cohort Study of the Benefits of Bydureon in Customary Clinical Care in the United States
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 28, 2014
Completion date
October 28, 2014
Enrollment
7,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes